Veeva Systems (NYSE: VEEV) today announced the newest release of Vault CRM Suite, the market-leading CRM system for life sciences. Vault CRM Campaign Manager is also now available as part of Vault CRM ...

Segment featuring Dr. Charles Lapp, ME/CFS Key Opinion Leader and founder of the Hunter-Hopkins Center is now available hereOCALA, Fla., Dec.

3, 2024 /PRNewswire/ -- Hansa Biopharma, "Hansa" (Nasdaq Stockholm ... a smart lock tailored specifically to... at 10:05 Q2 To Host CONNECT 25 Conference in Austin in May 2025 Q2 Holdings, Inc. , a ...

RedHill has been awarded a judgment of approximately $8 million plus costs in a summary judgment by the New York Supreme Court in its legal proceedings against Kukbo Co. Ltd The Court dismissed ...

RedHill has been awarded a judgment of approximately $8 million plus costs in a summary judgment by the New York Supreme Court in its legal proceedings against Kukbo Co. Ltd The Court dismissed the ...

pylori infection in adults. For full prescribing information see: www.Talicia.com. SOURCE RedHill Biopharma Ltd. Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of ...

Reddit is currently down for many who users, who are being met with an "upstream connect error" message and infinite loading times when they try to visit the site. Reddit outage reports spiked ...

U.S. stocks were higher, with the Dow Jones index gaining more than 400 points on Monday. Shares of BridgeBio Pharma, Inc. BBIO rose sharply during Monday's session after the company announced ...

免费获得康乃德生物(CNTB)期权数据。查看选定到期日的康乃德生物个股期权的认购、认沽执行价格、最新价、涨跌幅、成交量及更多股票期权相关信息。点击“分析”可查看康乃德生物股票期权的未平仓合约分析表格。

(RTTNews) - BridgeBio Pharma Inc. (BBIO) announced that the U.S. Food and Drug Administration approved Attruby or acoramidis, an orally-administered near-complete stabilizer of Transthyretin for ...